Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Thrombophilia 1Rectal Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1EGFR-Mutant Lung Cancer 1Deglutition Disorders 1Communication Disorders 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Pancreatic Ductal 1Carcinoma 1Brain Neoplasms 1Blood Coagulation Disorders 1Adenocarcinoma 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Lead × Clear all
NCT03658265 2020-10-08

Effects of Exercise Training at Different Timeline on Shoulder Dysfunction After Breast Cancer Modified Radical Mastectomy

Wuhan University

Phase NA Completed
200 enrolled
Breast

Breast Neoplasms

NCT00210197 2013-07-26

EHC

Institut Bergonié

Completed
48 enrolled
Breast

Blood Coagulation Disorders, Breast Neoplasms, Thrombophilia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡